BRIGHT MINDS BIOSCIENCES INC. - Common Stock, no par value (DRUG)

Historical Holders from Q3 2023 to Q3 2025

Symbol
DRUG on Nasdaq
Type / Class
Equity / Common Stock, no par value
Shares outstanding
7,096,625
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
6,034,640
Holdings value
$365,700,278
% of all portfolios
0.002%
Number of holders
62
Number of buys
36
Number of sells
-14
Average buys %
+0%
Average sells %
-0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of BRIGHT MINDS BIOSCIENCES INC. - Common Stock, no par value (DRUG)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
JANUS HENDERSON GROUP PLC 16.3% +1.9% $28,423,825 +$850,785 1,145,660 +3.1% JANUS HENDERSON GROUP PLC 30 Jun 2025
COMMODORE CAPITAL LP 7.2% $15,445,000 500,000 COMMODORE CAPITAL LP 31 Dec 2024
Vivo Opportunity Fund Holdings, L.P. 6.4% $27,550,801 454,184 Vivo Opportunity Fund Holdings, L.P. 30 Sep 2025
PERCEPTIVE ADVISORS LLC 6.3% $13,735,208 444,649 Perceptive Advisors LLC 31 Mar 2025
Adage Capital Management, L.P. 5.58% $24,005,770 395,743 Adage Capital Management, L.P. 30 Sep 2025
RA CAPITAL MANAGEMENT, L.P. 2.9% $6,376,530 206,427 RA Capital Management, L.P. 31 Mar 2025
Sio Capital Management, LLC 2.69% -65.4% $11,571,744 -$19,506,679 190,764 -62.8% Sio Capital Management, LLC 30 Sep 2025
Point72 Asset Management, L.P. 3% $4,175,988 135,189 Point72 Asset Management, L.P. 31 Dec 2024

Institutional Holders of BRIGHT MINDS BIOSCIENCES INC. - Common Stock, no par value (DRUG)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 6,034,640 $365,700,278 +$48,443,326 $60.66 62
2025 Q2 5,234,387 $136,973,710 -$2,453,899 $26.11 46
2025 Q1 5,217,399 $188,361,504 +$11,625,261 $36.07 34
2024 Q4 4,897,032 $176,406,965 +$167,324,812 $36.02 31
2024 Q3 191,547 $229,810 -$6,160 $1.17 6
2024 Q2 197,030 $207,191 -$19,280 $1.05 5
2024 Q1 213,375 $255,563 -$27,190 $1.2 7
2023 Q4 228,082 $329,806 +$48,212 $1.43 7
2023 Q3 194,505 $309,171 +$309,171 $1.6 5